Anti-BCLAF1
Overview
The Anti-BCLAF1 antibody (HPA027770) is a rabbit Triple A Polyclonal reagent recognising human BCL2-associated transcription factor 1 (BCLAF1), a nuclear protein implicated in transcriptional regulation, apoptotic signalling, and mRNA processing. The antibody is raised against a recombinant protein fragment corresponding to a defined BCLAF1 sequence region enriched in arginine–lysine–serine–rich motifs. Validated exclusively for immunohistochemistry, it enables localisation of BCLAF1 in fixed human tissues.
Highlights
- Rabbit Triple A Polyclonal antibody targeting human BCLAF1
- Validated only for immunohistochemistry (IHC)
- Recombinant antigen fragment representing regulatory low-complexity regions
- Formulated in PBS with glycerol and preservative
At-a-glance
- Antigen
- BCLAF1 (BCL2-associated transcription factor 1)
- Antibody type
- Triple A Polyclonal
- Host species
- Rabbit
- Isotype
- IgG
- Validation
- IHC only
- Immunogen sequence
- QKSPEIHRRIDISPSTLRKHTRLAGEERVFKEENQKGDKKLRCDSADLRHDIDRRRKERSKERGDSKGSRESSGSRKQEKTPKDYKEYKSYKDDSKHKREQDHSRSSSSSASPSSPSSR
- Buffer composition
- 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative.
- Condition
- New
Applications
This antibody facilitates immunohistochemical detection of BCLAF1 in human tissues, supporting studies of nuclear transcriptional regulation, apoptotic pathways, and RNA-associated complexes. It is suitable for evaluating BCLAF1 distribution in physiological and pathology-related contexts.
Sustainability
By rehoming surplus lab products, this listing supports waste reduction and resource efficiency.
